SAMURAI KOWA
LIVE

Serial Number

79380333

Owner

KOWA COMPANY, LTD.

Attorney

Erica Halstead

Filing Date

Aug 14, 2023

Add to watchlist:

No watchlists yet
View on USPTO

SAMURAI KOWA Trademark

Serial Number: 79380333 • Registration: 7592547

SAMURAI KOWA is a trademark filed by KOWA COMPANY, LTD. on August 14, 2023. The trademark is classified under Class 5 (Pharmaceuticals), Class 30 (Staple Foods), Class 32 (Light Beverages). The application is currently registered and active.

Owner Contact Info

KOWA COMPANY, LTD. (4 trademarks)

6-29, Nishiki 3-chome,

Entity Type: 03

Trademark Details

Filing Date

August 14, 2023

Registration Date

December 10, 2024

Published for Opposition

October 8, 2024

Goods & Services

Tea; coffee; coffee-based beverages; cocoa; cocoa-based beverages; chocolate confectionery; chocolate; ice cream for desserts; ice cream; western-style confectionery, namely, frozen confectionery; baked confectionery made of sugar; cakes; rice-based snack food; snacks, namely, granola snacks; flour-based snack foods; starch-based candies (ame); pellet-shaped rice crackers (arare); rice crackers; rice dumplings; bean-jam filled wafers (monaka); dried sugared cakes of rice flour (rakugan); ice candies; caramels; candies; cookies; chewing gum; doughnuts; candy containing dried fruit being confectionery; biscuits; fruit jelly candy; bread and buns; sandwiches; steamed buns stuffed with minced meat (niku-manjuh); hamburger sandwiches; pizzas; hot dog sandwiches; meat pies

Carbonated drinks, non-alcoholic; soft drinks; energy drinks, non-alcoholic; energy drinks; fruit juices; vegetable juices being beverages

Pharmaceutical preparations, namely, anti-inflammatory agents, analgesics, vitamin preparations, pharmaceutical tonics for the relief of muscular pain, shoulder stiffness, lumbar pain, eyestrain and fatigue for medical purposes, pharmaceutical preparations for the treatment of cardiovascular disorders and metabolic disorders, pharmaceutical preparations for the prevention and treatment of disorders of the metabolic system, pharmaceutical preparations for the treatment of glaucoma and ocular hypertension; pharmaceutical and biological preparations for the treatment of diseases of the central nervous system, peripheral nervous system, sensory organs, the circulatory system, respiratory system, and the digestive system; pharmaceutical substances for the treatment of dermatological diseases, allergies and urogenital or anal conditions; nutritional additives for medical purposes in the nature of dietary supplements for humans or animals; medicinal tonics for the relief of muscular pain, shoulder stiffness, lumbar pain, eyestrain and fatigue; dietary supplement for human use; hand-sanitizing preparations; disinfectants for sanitary purposes; antimicrobials for dermatologic use; vermin destroying preparations, fungicides, herbicides, insect-repellents; adhesive plasters for medical purposes, namely, for dressing wounds; crude drugs, namely, medicines made of rootstock, bark, leaves, fruits, seeds, rhinoceros' horn, musk or bear's gall, used for the treatment of pain, cold, fever, anemia, and for use as diuretics or astringents; absorbent cotton for medical purposes; adhesive plasters for sanitary purposes; bandages for dressings

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
May 31, 2025 FINO
FINAL DISPOSITION NOTICE SENT TO IB
May 14, 2025 FICS
FINAL DISPOSITION PROCESSED
May 13, 2025 FIMP
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Mar 22, 2025 OPNX
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Mar 10, 2025 FICR
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Mar 4, 2025 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Mar 4, 2025 OPNR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Dec 10, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Dec 10, 2024 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 8, 2024 NPUB
PUBLISHED FOR OPPOSITION
Oct 8, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 18, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 2, 2024 CNSA
EXAMINER'S AMENDMENT ENTERED
Aug 30, 2024 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Aug 30, 2024 GNEN
EXAMINERS AMENDMENT E-MAILED
Aug 30, 2024 GNEA
EXAMINERS AMENDMENT -WRITTEN
Aug 30, 2024 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 27, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 27, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 27, 2024 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Aug 1, 2024 GNRN
NON-FINAL ACTION E-MAILED
Aug 1, 2024 GNRT
NON-FINAL ACTION WRITTEN
Aug 1, 2024 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
May 24, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 24, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 24, 2024 TROA
REFUSAL PROCESSED BY IB
Apr 24, 2024 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Mar 28, 2024 RFCS
REFUSAL PROCESSED BY MPU
Mar 28, 2024 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Mar 8, 2024 RFCR
NON-FINAL ACTION WRITTEN
Mar 7, 2024 CNRT
ASSIGNED TO EXAMINER
Mar 1, 2024 DOCK
APPLICATION FILING RECEIPT MAILED
Oct 17, 2023 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 12, 2023 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Oct 11, 2023 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Oct 5, 2023 REPR